Description
Ibrutinib: a major breakthrough in the treatment of chronic lymphocytic leukaemia (CLL) and other lymphoproliferative disorders
€3.03
Ibrutinib: a major breakthrough in the treatment of chronic lymphocytic leukaemia (CLL) and other lymphoproliferative disorders
You must be logged in to post a review.
Reviews
There are no reviews yet.